[1]CurrentPatentAssignee:TAKEDAPHARMACEUTICALCOMPANYLIMITED-US5389641,1995,A
941294-39-9
951884-40-5
941294-35-5
941294-38-8
941294-34-4
85658-55-5
14959-33-2 | 3-Pyridazinamine, 6-bromo-N,N-dimethyl- | AA001LRR | MFCD11223476
14994-75-3 | 4-Hydroxy-1-phenyl-1H-quinolin-2-one | AA001M2L | MFCD00100779
150281-46-2 | 3-(Pyrrolidin-3-yl)pyridine | AA001MDX | MFCD01862540
150535-15-2 | methyl 2-(1,2,3,4-tetrahydroquinolin-2-yl)acetate | AA001MMU | MFCD24551416
151062-55-4 | (2S)-2-Amino-2-methyl-3-sulfanylpropanoic acid hydrochloride | AA001MYU | MFCD08063383
31691-23-3 | Poly(oxy-1,2-ethanediyl), α-(4-methylphenyl)-ω-hydroxy- | AA01X341 | MFCD00020600
155106-73-3 | Benzothiazole, 2-[4-(1,3-benzodioxol-5-ylmethyl)-1-piperazinyl]- | AA001NJ8 | MFCD00613285
155535-23-2 | 3-Chloro-pyrido[2,3-b]pyrazine | AA001NW9 | MFCD20925262
155877-83-1 | 4-(5,7,7,10,10-Pentamethyl-7,8,9,10-tetrahydro-5H-benzo[e]naphtho[2,3-b][1,4]diazepin-13-yl)benzoic acid | AA001O7Y | MFCD06798318
156276-25-4 | Isopropyl 2-hydroxy-4-methylpentanoate | AA001OKG | MFCD00059361